Major pharmacy companies agree to settle in nationwide opioid cases


CVS and Walgreens, two of the largest pharmacy chains in the country, have agreed to pay $5 billion each to settle lawsuits throughout the country over allegations of mishandling opioid prescriptions. The companies announced the settlement plan through government filings but need the approval of the myriad of plaintiffs before the deal can go into effect, The New York Times reports.
These settlements can potentially put an end to the decades of lawsuits regarding the role of the drug industry in the opioid epidemic, NPR reports. Opioid overdose was the cause of 80,000 deaths in 2021 alone and approximately 9.5 million Americans reported misusing opioids in 2020, according to CNN. Opioids are painkillers that can be illegal, like heroin, or prescribed by doctors, including morphine, oxycodone, and hydrocodone.
Previously, the companies tried fighting the lawsuits in court; they were unsuccessful, however, when a federal judge ordered them to pay $650 million to two Ohio counties in August, the Times continues. The jury explained that the companies seemed to turn a blind eye to alarming pill quantities and continued to dispense.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
CVS and Walgreens have specified that their willingness to pay settlements does not equate to an admission of wrongdoing. Along with CVS and Walgreens, Walmart has agreed to pay $3 billion in settlements as well.
CVS general counsel Thomas Moriarty said in a statement, "We are committed to working with states, municipalities, and tribes, and will continue our own important initiatives to help reduce the illegitimate use of prescription opioids."
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Devika Rao has worked as a staff writer at The Week since 2022, covering science, the environment, climate and business. She previously worked as a policy associate for a nonprofit organization advocating for environmental action from a business perspective.
-
The First Homosexuals: The Birth of a New Identity, 1869–1939
Feature Wrightwood 659, Chicago, through Aug. 2
-
Why the FDA wants to restrict kratom-related products
In the Spotlight The compound is currently sold across the United States
-
Israeli NGOs have started referring to Gaza as a 'genocide' — will it matter?
TODAY'S BIG QUESTION For the first time since fighting began in 2023, two Israeli rights groups have described their country's actions in the Gaza Strip as 'genocide' while famine threatens the blockaded Palestinian territory
-
Food may contribute more to obesity than exercise
Under the radar The devil's in the diet
-
Not just a number: how aging rates vary by country
The explainer Inequality is a key factor
-
Children's health has declined in the US
The Explainer It's likely a sign of larger systemic issues
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Is that the buzzing sound of climate change worsening sleep apnea?
Under the radar Catching diseases, not those ever-essential Zzs
-
Deadly fungus tied to a pharaoh's tomb may help fight cancer
Under the radar A once fearsome curse could be a blessing
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Climate change can impact our gut health
Under the radar The gastrointestinal system is being gutted